Authors
Latest:
2010 Technology Innovator of the Year: Tim Davis2010 Technology Innovator of the Year Tim Davis is plugged in, and uses technology every day to help patients and run his business more efficiently.
Latest:
Managed Care Biologics and InjectablesPayer response to new entrants to the multiple sclerosis (MS) market is mixed as some believe that there remain meaningful, major unmet needs in the MS category, according to The Zitter Group's Spring 2011 Managed Care Biologics and Injectables Index.
Latest:
Private-payer Costs for Employees with Treatment-resistant DepressionIndividuals with treatment-resistant depression do not achieve and sustain remission after multiple pharmacotherapies, with an unknown impact on employment. This study investigates the expenditures of TRD from a private-payer perspective in Canada.
Latest:
Dolutegravir Is Susceptible to Chelation-Type InteractionsCommon medications containing polyvalent cations should be separated to prevent decreased absorption of the HIV therapy.
Latest:
Patients With Pain Benefit From a Multimodal ApproachThis method may optimize pain control and could be an answer to the opioid crisis.
Latest:
Biosimilars Action Plan: There's No Better Time Than NowSeveral hurdles remain for biosimilars to flourish in the US market.
Latest:
HIV-Positive Patients with Comorbidities Benefit from Personalized, Pharmacist-Led CareHIV-specialized pharmacies meet the complex needs of HIV-positive patients, helping to provide comprehensive patient care and improve medication adherence to both anti-retroviral therapies and non-HIV medications.
Latest:
After Doughnut Hole Closure, Oral Anticancer Drug Costs Still Too High for ManyStudy finds that patients prescribed expensive drugs will continue to face high out-of-pocket costs.
Latest:
Focus on Hepatitis C: Bridging the Gap from New Drug Therapy to Successful TreatmentSpecialty pharmacists can help patients achieve successful outcomes in the treatment of hepatitis C by providing comprehensive clinical consultations on triple therapies.
Latest:
Connecting the Dots for a Digital Deploy: A Guide to Engaging Pharma StakeholdersStrategic tips for pharma to develop an overall business strategy around digital engagement.
Latest:
The Hidden Adherence Problem: HPV Vaccination Series Completion Is Not as Easy as 1, 2, 3Pharmacists can help improve vaccination completion rates.
Latest:
Identifying and Managing Fungal Skin InfectionsMoist, warm skin provides the ideal environment for dermatophytes—fungi that cause skin infections—to flourish.
Latest:
Statin-Fenofibrate Combination Therapy in an ACCORD Population: A Retrospective AnalysisRetrospective analysis of a population meeting criteria for the ACCORD lipid trial supported adjunct fenofibrate in patients with reduced low-density lipoprotein cholesterol and elevated triglycerides.
Latest:
Passing the First Test: How to Impress on the Residency InterviewWith more and more students applying for residency positions, off-site interviews are becoming an important first step in the selection process.
Latest:
Explore Ovarian Cancer Treatments Through Clinical TrialsGuidelines typically recommend debulking surgery, plus systemic chemotherapy for most patients.
Latest:
Pharmacy and Telehealth: An Interprofessional Model at a Student-led Free ClinicUnique model demonstrates how clinical pharmacy services could be integrated into an interprofessional telehealth clinic.
Latest:
The Evolution of the HIV Epidemic and the Role of Pharmacists: Where Are We 35 Years Later?In June of 1981 an unspeakable new disease entered the public consciousness in the United States and it did so quickly and unexpectedly, leaving illness, tragedy, and death in its wake.
Latest:
Zitter Health Insights and Specialty Pharmacy Times to Grant Awards in Specialty Pharmacy Customer SatisfactionThe Specialty Pharmacy Satisfaction Survey recognizes the top performing specialty pharmacies for achievements in customer satisfaction.
Latest:
Challenges and Innovations in the Manufacture of Hazardous DrugsUSP General Chapter , which was published by the United States Pharmacopeial Convention and updated most recently in December 2017, sets forth guidelines for the handling of hazardous drugs in the health care setting with the goal of promoting safety for patients and health care workers.
Latest:
Increases in Utilization Management of Oncology Medicines by US PayersRecent increases in the number of therapies indicated for a given oncology subtype has resulted in heightened utilization management stringency.
